RA2-18070-47470
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-04-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-20
Registered in v-safe
- 2021-04-20
- 2021-04-23
- 2021-04-30
- 2021-05-14
- 2021-05-22
- 2021-07-12
- 2021-10-08
-
2021-10-26
Dose 2 — Pfizer-BioNTech
- 2021-11-01
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-09
-
2022-01-27
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-26 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 2
Symptoms: Cold symptoms
Release 11 — 6 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release